| Variables . | Total . | Value . |
|---|---|---|
| Age (years), mean ± SD | 1105 | 74.2 ± 11.2 |
| Median (IQR) | 76.0 (67.0−83.0) | |
| NYHA class | 1052 | |
| I | 241 (22.9%) | |
| II | 254 (24.1%) | |
| II–III | 55 (5.2%) | |
| III | 9 (0.9%) | |
| No heart failure | 493 (46.9%) | |
| Cardiomyopathy | 456 | |
| Ischaemic | 235 (51.5%) | |
| Non-ischaemic | 159 (34.9%) | |
| Other | 62 (13.6%) | |
| Valvular heart disease | 1102 | 143 (13.0%) |
| Heart failure | 1103 | 285 (25.8%) |
| History of AF | 1100 | |
| None | 702 (63.8%) | |
| Permanent | 198 (18.0%) | |
| Paroxysmal | 154 (14.0%) | |
| Persistent | 46 (4.2%) | |
| Previous AF ablation | 1067 | 22 (2.1%) |
| History of thrombo-embolic events or stroke | 1069 | |
| None | 993 (92.9%) | |
| Stroke | 58 (5.4%) | |
| Transient ischaemic attack | 15 (1.4%) | |
| Peripheral arterial embolus | 3 (0.3%) | |
| LVEF (%), mean ± SD | 596 | 52.1 ± 15.0 |
| Median (IQR) | 55.0 (40.0−64.0) |
| Variables . | Total . | Value . |
|---|---|---|
| Age (years), mean ± SD | 1105 | 74.2 ± 11.2 |
| Median (IQR) | 76.0 (67.0−83.0) | |
| NYHA class | 1052 | |
| I | 241 (22.9%) | |
| II | 254 (24.1%) | |
| II–III | 55 (5.2%) | |
| III | 9 (0.9%) | |
| No heart failure | 493 (46.9%) | |
| Cardiomyopathy | 456 | |
| Ischaemic | 235 (51.5%) | |
| Non-ischaemic | 159 (34.9%) | |
| Other | 62 (13.6%) | |
| Valvular heart disease | 1102 | 143 (13.0%) |
| Heart failure | 1103 | 285 (25.8%) |
| History of AF | 1100 | |
| None | 702 (63.8%) | |
| Permanent | 198 (18.0%) | |
| Paroxysmal | 154 (14.0%) | |
| Persistent | 46 (4.2%) | |
| Previous AF ablation | 1067 | 22 (2.1%) |
| History of thrombo-embolic events or stroke | 1069 | |
| None | 993 (92.9%) | |
| Stroke | 58 (5.4%) | |
| Transient ischaemic attack | 15 (1.4%) | |
| Peripheral arterial embolus | 3 (0.3%) | |
| LVEF (%), mean ± SD | 596 | 52.1 ± 15.0 |
| Median (IQR) | 55.0 (40.0−64.0) |
Data are expressed as n (%) unless otherwise specified.
AF, atrial fibrillation; IQR, interquartile range; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; SD, standard deviation.
| Variables . | Total . | Value . |
|---|---|---|
| Age (years), mean ± SD | 1105 | 74.2 ± 11.2 |
| Median (IQR) | 76.0 (67.0−83.0) | |
| NYHA class | 1052 | |
| I | 241 (22.9%) | |
| II | 254 (24.1%) | |
| II–III | 55 (5.2%) | |
| III | 9 (0.9%) | |
| No heart failure | 493 (46.9%) | |
| Cardiomyopathy | 456 | |
| Ischaemic | 235 (51.5%) | |
| Non-ischaemic | 159 (34.9%) | |
| Other | 62 (13.6%) | |
| Valvular heart disease | 1102 | 143 (13.0%) |
| Heart failure | 1103 | 285 (25.8%) |
| History of AF | 1100 | |
| None | 702 (63.8%) | |
| Permanent | 198 (18.0%) | |
| Paroxysmal | 154 (14.0%) | |
| Persistent | 46 (4.2%) | |
| Previous AF ablation | 1067 | 22 (2.1%) |
| History of thrombo-embolic events or stroke | 1069 | |
| None | 993 (92.9%) | |
| Stroke | 58 (5.4%) | |
| Transient ischaemic attack | 15 (1.4%) | |
| Peripheral arterial embolus | 3 (0.3%) | |
| LVEF (%), mean ± SD | 596 | 52.1 ± 15.0 |
| Median (IQR) | 55.0 (40.0−64.0) |
| Variables . | Total . | Value . |
|---|---|---|
| Age (years), mean ± SD | 1105 | 74.2 ± 11.2 |
| Median (IQR) | 76.0 (67.0−83.0) | |
| NYHA class | 1052 | |
| I | 241 (22.9%) | |
| II | 254 (24.1%) | |
| II–III | 55 (5.2%) | |
| III | 9 (0.9%) | |
| No heart failure | 493 (46.9%) | |
| Cardiomyopathy | 456 | |
| Ischaemic | 235 (51.5%) | |
| Non-ischaemic | 159 (34.9%) | |
| Other | 62 (13.6%) | |
| Valvular heart disease | 1102 | 143 (13.0%) |
| Heart failure | 1103 | 285 (25.8%) |
| History of AF | 1100 | |
| None | 702 (63.8%) | |
| Permanent | 198 (18.0%) | |
| Paroxysmal | 154 (14.0%) | |
| Persistent | 46 (4.2%) | |
| Previous AF ablation | 1067 | 22 (2.1%) |
| History of thrombo-embolic events or stroke | 1069 | |
| None | 993 (92.9%) | |
| Stroke | 58 (5.4%) | |
| Transient ischaemic attack | 15 (1.4%) | |
| Peripheral arterial embolus | 3 (0.3%) | |
| LVEF (%), mean ± SD | 596 | 52.1 ± 15.0 |
| Median (IQR) | 55.0 (40.0−64.0) |
Data are expressed as n (%) unless otherwise specified.
AF, atrial fibrillation; IQR, interquartile range; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; SD, standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
